Rodrigo Assar: Modeling and Simulation to Improve Thrombosis and Hemostasis Care
Rodrigo Assar, Senior Data Scientist at Globant, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Cardiovascular Medicine, adding:
”Excited to share our latest editorial publication in Frontiers in Cardiovascular Medicine!
I am thrilled to announce the publication of our editorial: ‘Innovative Modeling and Simulation in Thrombosis and Hemostasis: Enhancing Diagnosis and Treatment,’ co-authored with my colleague Daria Hemmerling.
This publication marks the perfect closure to an incredible and highly productive year, reaching a total of 14 publications across our core research topics in data science, computational modeling, biostatistics, and healthcare AI.
Huge thanks to all co-authors, reviewers, and collaborators who made this milestone possible!”
Title: Innovative modeling and simulation in thrombosis and hemostasis: enhancing diagnosis and treatment
Authors: Rodrigo Assar, Daria Hemmerling
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A